A method for preparing a highly active plasmin and the plasmin itself.

By separating and purifying plasminogen and then subjecting it to heat treatment at 80-85℃, combined with incubation with urokinase, the problem of insufficient plasmin activity was solved, achieving an efficient and simplified plasmin preparation process that improves the activity and purity of plasmin.

CN123063383APending Publication Date: 2026-11-10CHINA AGRI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611152812.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-07-31
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

In existing technologies, the separation, purification, and activation steps of plasmin are fragmented, failing to effectively utilize the potential of heat treatment to improve plasmin activity, resulting in high subsequent activation costs and insufficient activity.

Method used

After the plasminogen is isolated and purified, it is heat-treated at 80-85℃ for 60-90 seconds, and then incubated with urokinase to prepare highly active plasmin.

Benefits of technology

It significantly improved the specific activity of plasmin by 20%, simplified the process, and improved the purity and storage stability of the final product.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123063383A_ABST
    Figure CN123063383A_ABST
Patent Text Reader

Abstract

This invention discloses a method for preparing highly active plasminogen activator and the resulting plasmin. The method innovatively introduces a heat treatment step under specific conditions after plasminogen purification, namely, treatment at 80-85°C for 60-90 seconds. This method overcomes the technical prejudice in the art that high temperatures impair the activation potential of plasminogen activator (PG). The heat-treated PG, upon subsequent activation, exhibits synergistic effects, significantly increasing the specific activity of the resulting plasmin by nearly 20% compared to plasmin without this heat treatment. This process, while enhancing activity, also sterilizes and inactivates impurities, simplifies the process, and its parameters are easily scaled up industrially, providing an efficient and economical new approach to obtaining high-performance plasmin products.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the fields of biochemical engineering and enzyme preparation technology, and particularly to a method for preparing a highly active plasmin and the plasmin itself. Background Technology

[0002] In current understanding, the standard procedure for obtaining high-purity plasmin (PL) from raw materials such as milk involves two steps. The first step is precursor separation; that is, separating and purifying plasminogen (PG) from the complex milk matrix using physicochemical methods such as chromatography and precipitation. This step aims to obtain a stable and easily stored PG intermediate. The second step is in vitro activation; when PL with fibrinolytic activity is needed, the purified PG is activated in vitro using plasminogen activators (such as urokinase) or by altering microenvironmental conditions such as acidic pH, converting it into the active form of plasmin.

[0003] The deficiency or technical bias in existing technologies lies in the industry's general view of separation, purification, and activation as two independent, completely separate processes. Especially at the industrial production level, the treatment of PG intermediates typically stops at separation and purification, aiming to obtain a stable single component. Activation is then performed when active PL is required. This separate approach fails to consider that immediate post-purification heat treatment not only serves the conventional functions of sterilization and inactivation of other enzymes but also acts as a unique "pre-activation" method, significantly enhancing the activation potential of PG. This allows for the acquisition of a final PL product with higher catalytic activity in subsequent activation steps at the same or lower activation cost.

[0004] How to pretreat PG intermediates through a simple and controllable physicochemical method to non-obviously optimize their molecular conformation, thereby generating PL products with higher specific activity in subsequent activation, has become an unrecognized and urgent technical problem in this field. Summary of the Invention

[0005] To address the aforementioned problems in the prior art, this invention proposes a method for preparing highly active plasmin and the plasmin thereof.

[0006] On the one hand, the present invention provides a method for preparing highly active plasmin, comprising the following steps: S1: Plasminogen is isolated and purified from animal milk raw materials; S2: The plasminogen obtained in step S1 is subjected to heat treatment at a temperature of 80~85℃ for a duration of 60~90s. S3: After adding urokinase to a final concentration of 5 μg / mL, incubate to obtain plasmin.

[0007] In one specific embodiment of the present invention, in step S1, the animal milk raw material is cow milk, buffalo milk, goat milk or camel milk.

[0008] In one specific embodiment of the present invention, in step S1, the separation and purification method is to sequentially use fractional ammonium sulfate precipitation, lysine affinity chromatography and gel filtration for separation and purification.

[0009] In one specific embodiment of the present invention, in step S2, the heat treatment method is selected from water bath heating, microwave heat treatment or instantaneous pasteurization treatment.

[0010] In one specific embodiment of the present invention, in step S2, the heat treatment is first performed at 80~85℃ for 60~90s, followed by treatment at 135~145℃ for 2~4s.

[0011] In one specific embodiment of the present invention, in step S3, the incubation is performed at 37°C for 15-20 minutes.

[0012] In one specific embodiment of the present invention, step S2 and step S1 are performed directly and continuously, without a long-term low-temperature storage step in between.

[0013] On the other hand, the present invention provides a highly active plasminogen activator prepared according to the above preparation method.

[0014] In another aspect, the present invention provides an application of the highly active fibrinolytic enzyme prepared by the above preparation method in the preparation of highly efficient thrombolytic agents, proteolytic enzyme preparations, or biochemical research reagents.

[0015] Compared with the prior art, the present invention has the following beneficial effects.

[0016] The preparation method provided by this invention, which introduces a specific heat treatment step before PG activation, brings significant and unexpected technical effects. Firstly, the core technical effect of this invention lies in the fact that the specific activity (i.e., catalytic activity per unit mass of enzyme protein) of plasmin PL obtained from PG after heat treatment at 80-85℃ for 60-90 seconds is nearly 20% higher than that obtained by directly activating PG raw materials from untreated PG at the same temperature but different times. This improvement is not a simple additive effect of the steps, but rather a synergistic effect produced by the specific heat treatment conditions and the activation step, which is something that those skilled in the art could not have predicted based on conventional understanding.

[0017] Secondly, the heat treatment step in this invention not only enhances activity but also plays a positive role compared to traditional heat treatment, such as effectively killing microorganisms and inactivating residual enzymes in the raw materials that may affect PL stability, such as alkaline proteases. This achieves multiple benefits by creatively integrating the previously separate "sterilization / inactivation" and "PG pretreatment" steps, simplifying the process and improving the purity and storage stability of the final product, PL.

[0018] The heat treatment step in this invention not only enhances activity but also plays a positive role compared to traditional heat treatment, such as effectively killing microorganisms and inactivating residual enzymes (e.g., alkaline proteases) that may affect PL stability in the raw materials. This multi-pronged approach creatively integrates the previously separate "sterilization / inactivation" and "PG pretreatment" steps, simplifying the process and improving the purity and storage stability of the final PL product.

[0019] In summary, this invention creatively integrates a precisely controlled specific heat treatment step into the PG to PL conversion process, overcoming the technical prejudice of those skilled in the art that "high temperature will damage PG." It achieves a substantial leap in the activity of the final product plasmin in a simple, efficient, and low-cost manner, and has outstanding industrial application value. Attached Figure Description

[0020] The present invention will be further described below with reference to the accompanying drawings and embodiments.

[0021] Figure 1 The effect of 75℃ heat treatment on plasminogen-derived activity and activation rate; Figure 2 The effect of 80℃ heat treatment on plasminogen-derived activity and activation rate; Figure 3 The effect of heat treatment at 85℃ on plasminogen-derived activity and activation rate. Detailed Implementation

[0022] In the following examples, unless otherwise specified, all experimental instruments and raw materials involved are commercially available products.

[0023] Example The highly active plasmin was prepared according to the following steps: 1. Isolate and purify plasminogen; Take 1 L of milk and immediately refrigerate at 4 °C. Centrifuge at 10,000 ×g for 30 min to remove the upper layer of fat and the bottom cell debris, and collect the skim milk supernatant. Adjust the pH of the skim milk to 4.6 with 1 mol / L HCl, let it stand for 30 min, and then centrifuge at 10,000 ×g for 30 min at 4 °C. Collect the supernatant, which is the whey. Add solid ammonium sulfate to the whey to 40% saturation, stir at 4 °C for 30 min, centrifuge at 10,000 ×g for 20 min, and discard the precipitate to remove impurities. Continue to add solid ammonium sulfate to the supernatant to 80% saturation, stir at 4 °C for 30 min, centrifuge at 10,000 ×g for 20 min, and collect the precipitate. The precipitate was dissolved in a small amount of 0.05 mol / L Tris-HCl buffer (pH 7.4), and the solution was transferred to a dialysis bag. Dialysis was performed overnight at 4°C with the same buffer, changing the dialysis buffer three times to completely remove ammonium sulfate. After dialysis, the sample was centrifuged at 10,000 × g for 20 min, and the supernatant was collected as the crude PG extract from milk. This extract was stored at 4°C for later use or for subsequent purification. The entire process was performed at low temperatures to maintain the stability of the PG.

[0024] The crude PG extract from milk, after ammonium sulfate fractionation and dialysis, was centrifuged at 10,000 × g for 20 min, and the supernatant was collected for later use. An appropriate amount of Lysine-Sepharose 4B affinity chromatography gel was weighed and fully swollen in 0.05 mol / L Tris-HCl buffer (pH 7.4) at 4 °C. The gel was then washed three times with the same buffer, allowing it to stand for 10 min each time before discarding the supernatant to remove preservatives from the gel preservation solution. The treated gel was mixed with the supernatant of the crude extract at a volume ratio of 1:2 and placed in a chromatography refrigerator. The mixture was slowly stirred with a magnetic stirrer at 4 °C for 2 h to ensure sufficient binding of PG in the sample to lysine ligands on the gel. After stirring, carefully load the mixture into the chromatography column, maintaining a column height of 10–15 cm. Allow the gel to settle naturally. Once the liquid on the gel surface has dried, wash the column with 5 column volumes of 0.05 mol / L Tris-HCl buffer (pH 7.4) at a flow rate of 0.5 mL / min to remove unbound proteins, while monitoring the absorbance of the eluent at 280 nm. Stop washing when the absorbance drops below 0.05. Then, replace the eluent with 0.05 mol / L Tris-HCl buffer (pH 7.4) containing 0.2 mol / L 6-aminocaproic acid, and elute at the same flow rate. Collect 2 mL of eluent per tube. Transfer the combined eluent to an ultrafiltration concentration tube and centrifuge at 3,000 × g at 4 °C until the sample volume is reduced to one-fifth of its original volume. The concentrated sample was diluted to its original volume with 0.05 mol / L Tris-HCl buffer (pH 7.4) and then concentrated again. This process was repeated twice to remove 6-aminocaproic acid from the eluent. The concentrated affinity chromatography-purified sample was collected and further purified by gel filtration chromatography to obtain plasminogen. 2. Activation treatment of purified plasminogen Plasminogen was activated at 75℃, 80℃, and 85℃ for different durations (15 s, 30 s, 60 s, 90 s, and 120 s), and then heated to 140℃ for a brief 4 s.

[0025] 3. Preparation of plasmin Add urokinase to the activated plasminogen solution to a final concentration of 5 μg / mL, mix gently, and incubate at 37°C for 15 min to fully activate PG into plasmin.

[0026] After incubation, the chromogenic substrate D-Val-Leu-Lys-pNA dihydrochloride was rapidly added to each well to a final concentration of 0.2 mmol / L. The microplate was immediately placed in a microplate reader preheated to 37 ℃, and the absorbance was continuously monitored at 405 nm, with readings taken every 30 s for 30 min. The initial reaction rate was recorded. For the blank control wells, an equal volume of simulated ultrafiltrate milk was used to replace the PG solution sample in the simulation system; all other reagents remained the same. This was used to subtract background absorption. Standards were PG standards with known specific activities, measured under the same conditions, and a standard curve was plotted. The PG-derived activity units of the test samples were calculated based on the standard curve. An activity unit was defined as the amount of enzyme required to release 1 μmol of p-nitroaniline per minute.

[0027] All experiments were performed in triplicate. Results are expressed as mean ± standard deviation (Mean ± SD). Statistical analysis was performed using SPSS 26.0 and GraphPad Prism 8 software. Duncan's multiple comparisons were used for post-hoc testing, and p < 0.05 was considered statistically significant.

[0028] When the heat treatment temperature was 75 ℃, the PG derivatization activity showed a trend of first increasing and then decreasing with increasing treatment time; when the treatment time was less than 90 s, the PG derivatization activity gradually increased; when the treatment time was greater than 90 s, the opposite trend was observed; the highest derivatization activity was obtained at 90 s. When the heat treatment temperature was 75 ℃, the PG activation rate showed a trend of first increasing and then decreasing with increasing treatment time; the highest activation rate was obtained at treatment times of 60 s and 90 s; when the treatment time was greater than 90 s, the activation rate decreased significantly (p < 0.05), and this trend was basically consistent with the variation law of PG derivatization activity. Figure 1 ).

[0029] When the heat treatment temperature was 80 ℃, the PG derivatization activity showed a trend of first increasing and then decreasing with increasing treatment time. The PG derivatization activity was lowest at treatment times of 15 s and 30 s, reaching its highest level at 60 s and 90 s (p < 0.05). Further increasing the time to 120 s significantly reduced the derivatization activity (p < 0.05), but it was still higher than that of the 15 s and 30 s treatment groups. It is noteworthy that compared to the groups with a heat treatment temperature of 75 ℃, the groups with a heat treatment temperature of 80 ℃ showed generally higher PG derivatization activity, indicating that increasing the heat treatment temperature can enhance the thermal response of PG activation. When the heat treatment temperature was 80 ℃, the PG activation rate showed a trend of first increasing and then decreasing with increasing treatment time. The highest activation rate was obtained at a treatment time of 60 s. When the treatment time exceeded 60 s, the activation rate gradually decreased, a trend basically consistent with the variation of PG derivatization activity. Figure 2 ).

[0030] When the heat treatment temperature was 85 °C, the PG derivatization activity showed a trend of first increasing and then decreasing with increasing treatment time. The PG derivatization activity was lowest at 15 s, and reached its highest level at 30 s and 60 s (p < 0.05). Further increasing the time to 90 s significantly reduced the PG derivatization activity (p < 0.05), but it was still higher than the 15 s treatment group. Notably, compared to the groups with heat treatment temperatures of 75 °C and 80 °C, the groups with a heat treatment temperature of 85 °C showed higher overall PG derivatization activity, and the shortest treatment time (30 s) was required to achieve the highest derivatization activity. This indicates that the 85 °C treatment temperature may be close to the critical treatment threshold for PG conformational rearrangement, thus allowing for sufficient exposure of the activation sites within the PG domain within a very short treatment time, thereby significantly improving its activation efficiency. When the heat treatment temperature is 85 ℃, the PG activation rate first increases and then decreases with increasing treatment time; the highest activation rate is obtained when the treatment time is 30 s; when the treatment time exceeds 60 s, the activation rate gradually decreases, and this trend is basically consistent with the change law of PG derivatization activity. This indicates that under the condition of heat treatment temperature of 85 ℃, 30 s is the critical condition for the change of PG activation effect. Figure 3 ).

[0031] In summary, heat treatment exhibits a bidirectional regulatory effect on PG derivatization activity and activation rate; that is, the enhancement or inhibition of the activation effect depends on the treatment method and intensity. Heat treatment yields significantly higher PG derivatization activity and activation rate than other treatment methods. Furthermore, as the heat treatment temperature increases, the treatment time required to reach the maximum activation level of PG derivatization activity gradually decreases. Specifically, the 75 ℃ treatment group exhibits a "mildly promoting" activation characteristic, with PG derivatization activity and activation rate significantly inhibited when the treatment time exceeds 90 s; the 80 ℃ treatment group exhibits a "relatively robust" activation characteristic, with PG derivatization activity and activation rate significantly inhibited when the treatment time exceeds 60 s; and the 85 ℃ treatment group exhibits a "relatively vigorous" activation characteristic, with PG derivatization activity and activation rate significantly inhibited when the treatment time is 30 s. These results indicate that the effect of heat treatment on PG activation is not linearly cumulative, but is jointly regulated by "conformational transformation behavior" and "thermal denaturation behavior." When the heat treatment intensity is insufficient to inactivate PG, as the treatment intensity increases, the PG conformation is partially expanded or relaxed, the exposure of the activation site-related region increases, and the activation efficiency is improved. When the heat treatment intensity is sufficient to inactivate PG, as the treatment intensity increases, PG undergoes irreversible denaturation, molecular aggregation, and activation site masking, and the activation efficiency is suppressed.

Claims

1. A method for preparing a highly active plasmin, characterized in that... Includes the following steps: S1: Plasminogen is isolated and purified from animal milk raw materials; S2: The plasminogen obtained in step S1 is subjected to heat treatment at a temperature of 80~85℃ for a duration of 60~90s. S3: After adding urokinase to a final concentration of 5 μg / mL, incubate to obtain plasmin.

2. The preparation method according to claim 1, characterized in that, In step S1, the animal milk raw material is cow milk, buffalo milk, goat milk, or camel milk.

3. The preparation method according to claim 1, characterized in that, In step S1, the separation and purification method is to sequentially use fractional ammonium sulfate precipitation, lysine affinity chromatography, and gel filtration for separation and purification.

4. The preparation method according to claim 1, characterized in that, In step S2, the heat treatment method is selected from water bath heating, microwave heat treatment or instantaneous pasteurization.

5. The preparation method according to claim 1, characterized in that, In step S2, the heat treatment is first performed at 80~85℃ for 60~90s, followed by treatment at 135~145℃ for 2~4s.

6. The preparation method according to claim 1, characterized in that, In step S3, the incubation is performed at 37°C for 15-20 minutes.

7. The preparation method according to claim 1, characterized in that, Step S2 is performed directly and continuously from step S1, without any long-term low-temperature storage steps in between.

8. A highly active fibrinolytic enzyme prepared according to any one of claims 1 to 7.

9. The application of the highly active fibrinolytic enzyme prepared by the preparation method according to any one of claims 1 to 7 in the preparation of highly efficient thrombolytic agents, proteolytic enzyme preparations, or biochemical research reagents.